Placebo-adjusted mean weight loss of 16.3% (39 lbs) at 180 mg and 16.0% (37 lbs) at 240 mg at 44 weeks with no evidence of weight loss plateau in ACCESS II, demonstrating highest efficacy among oral G ...
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the 'Company'), a clinical-stage biopharmaceutical company focused on its Phase ...
You shouldn’t have to sit in traffic — one closure is scheduled for roadwork on provincial highways in Hamilton on March 16, ...
Professions earning more than $100,000 a year had the worst average score (6.7), while the those earning less than $35,000 ...
O VER THE past decade commercial-satellite images have become the lifeblood of open-source intelligence (OSINT), allowing ...
In 2016, BNP Paribas Open official Raymond Moore claimed that women's tennis “rides on the coattails” of men's. He resigned ...
SanDisk (NASDAQ:SNDK) is climbing roughly 6% in Friday trading, with shares touching $655 as of midday. The move extends a powerful run that has made SNDK one of the most talked-about names in the ...
As one would expect, artificial intelligence was a top theme at the recent MWC conference in Barcelona, but 6G was certainly prominent as well. This year, the discussions has pivo ...
The highly resilient U.S. economy was already showing signs of strain even before the launch of the Iran war, data released ...
The Commerce Department on Friday released the January 2026 PCE inflation report, which showed the Federal Reserve's preferred inflation gauge remained stubbornly high for consumers.
When it succeeds 5G in 2030, the next-gen mobile network will focus on upload speeds, AI, and radar-like “sensing” of ...
Zealand Pharma plans to open a new research facility in Boston, part of the obesity drugmaker’s effort to expand its presence in the US. The Danish company will likely hire between 50 and 100 people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results